Eris Opens Strong on Subsidiary Stake Buyout Plan, Ends Weak

As on 25 Nov 2025,

opened on a positive note after announcing plans to acquire the remaining 30% stake in Swiss Parenterals for ₹423.3 crore, with consideration issued via 23.06 lakh preferential shares. The stock traded at its highest level since 15 September 2025 and reclaimed the ₹1700 mark after two months. However, the early gains faded through the session, and the stock finally closed nearly 2% lower, reflecting a sharp shift in intraday sentiment. 📌 Disclaimer: This content is for information only and not investment advice. Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Please consult a SEBI-registered advisor before making any investment decisions.